rakeshishere
HELP AND SUPPORT
FDA Approves Triple Combination HIV Drug
The Food and Drug Administration on Wednesday approved a pill to treat HIV infection that combines three widely used antiretroviral drugs into one pill.
The drug will be sold under the brand-name Atripla in the U.S. by Bristol-Myers Squibb Co. (BMY) and Gilead Sciences Inc. (GILD). Merck & Co. (MRK) will be involved in marketing the drug in countries outside the U.S.
SOURCE:*www.easybourse.com/Website/dynamic/News.php?NewsID=19460&lang=fra&NewsRubrique=2
The Food and Drug Administration on Wednesday approved a pill to treat HIV infection that combines three widely used antiretroviral drugs into one pill.
The drug will be sold under the brand-name Atripla in the U.S. by Bristol-Myers Squibb Co. (BMY) and Gilead Sciences Inc. (GILD). Merck & Co. (MRK) will be involved in marketing the drug in countries outside the U.S.
SOURCE:*www.easybourse.com/Website/dynamic/News.php?NewsID=19460&lang=fra&NewsRubrique=2